NCT05463874

Brief Summary

The purpose of this study is to see if a mindful self-compassion program given virtually can improve emotional distress for youth with type 1 diabetes, compared to routine care as usual.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 19, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 4, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

February 18, 2025

Status Verified

February 1, 2025

Enrollment Period

5 months

First QC Date

July 12, 2022

Last Update Submit

February 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diabetes Distress as measured by the Problem Areas in Diabetes - Teen Version (PAID-T)

    Diabetes distress as measured by the PAID-T will be compared in those who complete the MSC program to those in the wait-list control group at 3 months. Scores can range from 26-156, with scores of \<70, 70-90, and \>90 representing none-to-mild, moderate, and severe diabetes distress, respectively.

    3 months

Secondary Outcomes (5)

  • Anxiety as measured by the Generalized Anxiety 7-item scale (GAD-7)

    3 months, 12 months

  • Depression as measured by the Patient Health Questionnaire (PHQ-9)

    3 months, 12 months

  • Disordered eating as measured by the Diabetes Eating Problem Survey, revised version (DEPS-R)

    3 months, 12 months

  • Suicidal ideation as measured by the Patient Health Questionnaire (PHQ-9)

    3 months, 12 months

  • Diabetes distress as measured by the Problem Areas in Diabetes - Teen version (PAID-T)

    12 months

Other Outcomes (3)

  • Interaction term of time and diabetes distress

    Baseline, 8 weeks, 3 months, 6 months, 12 months

  • Hemoglobin A1c

    Baseline, 12 months

  • Time in Range

    Baseline, 8 weeks, 3 months, 6 months, 12 months

Study Arms (2)

Mindful Self-Compassion Arm

EXPERIMENTAL

Participants in this arm will participate in an 8-week virtual mindful self-compassion program.

Behavioral: Mindful Self-Compassion Program

Wait-list Control Arm

NO INTERVENTION

Participants in this arm will receive usual clinical care and will have the opportunity to participate in the mindful self-compassion program at the end of the study.

Interventions

The intervention consists of 8 sessions, one per week for 8 weeks, that last 1 hour and 30 minutes each. These sessions will cover a variety of mindfulness and self-compassion practices, such as dealing with difficult emotions and developing a kind inner voice.

Mindful Self-Compassion Arm

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Between 12-17 years of age
  • Diagnosed with type 1 diabetes at least 6 months prior to enrollment
  • Able to provide informed consent

You may not qualify if:

  • Unable or unwilling to provide informed consent
  • Do not speak English or French with enough fluency to complete all study related tasks
  • Presence of an intellectual disability that would preclude participation in the MSC intervention, as assessed by the treating physician
  • Lifetime diagnosis of a serious mental illness given by a clinician (e.g., psychotic or bipolar disorders), as these often involve intensive treatments with psychological and/or pharmacologic implications, which may confound our results.
  • Presence of acute suicidality at the time of enrollment (if a patient reports suicidality on the baseline questionnaires, a same-day assessment will be conducted to assess for acute suicidality. If present, the patient will receive immediate clinical attention and will no longer be eligible to participate in the study).
  • Active participation in another mental health intervention trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Eastern Ontario

Ottawa, Ontatrio, K1H8L1, Canada

Location

Related Publications (1)

  • Dover S, Ahmet A, Bluth K, Feldman BM, Goldbloom EB, Goldfield GS, Hamilton S, Imran O, Khalif A, Khatchadourian K, Lawrence S, Leonard A, Liu K, Ouyang Y, Peeters C, Shah J, Spector N, Zuijdwijk C, Robinson ME. Teaching Adolescents With Type 1 Diabetes Self-Compassion (TADS) to Reduce Diabetes Distress: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Dec 26;12:e53935. doi: 10.2196/53935.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Marie-Eve Robinson, MD, MSc

    Children's Hospital of Eastern Ontario

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 12, 2022

First Posted

July 19, 2022

Study Start

October 4, 2022

Primary Completion

March 1, 2023

Study Completion

April 1, 2024

Last Updated

February 18, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

IPD will be made available upon reasonable request from other researchers.

Locations